FDA Inspection 1092816 — Anil C. Odhav, M.D.

Anil C. Odhav, M.D. — FEI 3015201829

The FDA completed an inspection of Anil C. Odhav, M.D. on June 10, 2019 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 10, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports
756021 CFR 312.60FD-1572, protocol compliance